Replies to post #119763 on Biotech Values

[DewDiligence]

A UK private equity firm is very angry at 3M for allegedly botching the commercialization of the BacLite device for testing MRSA:

http://finance.yahoo.com/news/Allegations-Against-3M-prnews-2178199456.html?x=0&.v=1

The timing may be related to yesterday’s announcement by 3M of a competing product (#msg-62952504).

[DewDiligence]

More on 3M’s contribution to stamping out HAIs:

http://finance.yahoo.com/news/3M-Announces-Solution-to-bw-26064546.html?x=0&.v=1

If hospital administrators can see this issue in terms of hard dollars, there’s a better chance of reducing infections.